Ariz. Admin. Code § 4-21-101

Current through Register Vol. 30, No. 44, November 1, 2024
Section R4-21-101 - Definitions

In addition to the definitions in A.R.S. § 32-1701, the following apply to this Chapter:

"Accredited" means approved by the ACOE.

"ACCME" means Accreditation Council for Continuing Medical Education

"ACOE" means the Accreditation Council on Optometric Education.

"Active license" means a license that is current and has not expired.

"Advertisement" means a written, oral, or electronic communication that an ordinary person would perceive is designed to influence, directly or indirectly, a decision regarding ophthalmic goods or optometric services.

"Applicant" means:

An individual who applies to the Board under A.R.S. §§ 32-1722 or 32-1723 and A.A.C. R4-21-201 or R4-21-202 for a license to practice the profession of optometry, but has not been granted the license;

A licensee who applies under A.R.S. § 32-1726 and R4-21-205 for license renewal;

A licensee who applies under A.R.S. § 32-1728 and R4-21-208 for a pharmaceutical agent number;

A licensee or provider of Continuing Education that applies for approval of a Continuing Education under R4-21-210

"Application package" means the forms, documents, and fees that the Board requires an applicant to submit or have submitted on the applicant's behalf.

"Approved Continuing Education" means a planned educational experience relevant to the practice of the profession of optometry that the Board determines meets the criteria at R4-21-210.

"ARBO" means the Association of Regulatory Boards of Optometry.

"Audit" means the selection of licensees and process of reviewing documents for verification of satisfactory completion of Continuing Education requirements during a specified time period.

"CPR" means Cardiopulmonary Resuscitation.

"CELMO" means the Council on Endorsed Licensure Mobility for Optometrists.

"Certificate of special qualification" means a document that specifies whether the holder, who was licensed by the Board before July 1, 2000, and has not completed a course of study approved by the Board, may prescribe, administer, and dispense a pharmaceutical agent and if so, whether the holder may prescribe, administer, and dispense:

A topical diagnostic pharmaceutical agent only, or

Topical diagnostic and topical therapeutic pharmaceutical agents.

"Continuing Education" means planned, organized learning acts designed to maintain, improve, or expand a licensee's knowledge and skills in order for the licensee to develop new knowledge and skills relevant to the enhancement of practice, education, or theory development to improve the safety and welfare of the public.

"Continuing Education Report" means an online education report used to electronically track Continuing Education hours taken by a licensee.

"COPE" means the Council on Optometric Practitioner Education.

"Course of study" as used in A.R.S. § 32-1722, means education approved by the Board under R4-21-207 that qualifies an optometrist to prescribe, administer, and dispense topical diagnostic, topical therapeutic, and oral pharmaceutical agents.

"DEA" means The Drug Enforcement Administration

"Drug Enforcement Administration" means the Drug Enforcement Administration in the Department of Justice.

"DEA Controlled Substance Registration" means registration required and permitted by 21 U.S.C. 823 of the Controlled Substances Act.

"Injectable Epinephrine" means an intramuscular dose of epinephrine used for emergency treatment of an allergic reaction and delivered by a spring-loaded syringe.

"Good cause" means a reason that is substantial enough to afford a legal excuse.

"Hour of Continuing Education" means no less than 50 minutes of learning in one hour of time.

"Incompetence," as used in A.R.S. § 32-1701(8), means lack of professional skill, fidelity, or physical or mental fitness, or substandard examination or treatment while practicing the profession of optometry.

"Low vision" means chronic impairment to vision that significantly interferes with daily routine activities and cannot be adequately corrected with medical, surgical, or therapeutic means or conventional eyewear or contact lenses.

"Low-vision rehabilitation" means use of optical and non-optical devices, adaptive techniques, and community resources to assist an individual to compensate for low vision in performing daily routine activities.

"Negligence," as used in A.R.S. § 32-1701(8), means conduct that falls below the standard of care for the protection of patients and the public against unreasonable risk of harm and that is a departure from the conduct expected of a reasonably prudent licensee under the circumstances.

"OE Tracker" means the ARBO Online Education Tracker used to electronically track Continuing Education hours taken by a licensee.

"Opiate" or "Opioid" means any drug or other substance having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability.

"Oral pharmaceutical agent," as used in A.R.S. § 32-1728, means an ingested prescription or non-prescription substance used to examine, diagnose, or treat disease of the eye and its adnexa.

"Party" has the same meaning as prescribed in A.R.S. § 41-1001.

"Plano lenses" means contact lenses that have cosmetic function only.

"Practice management" means the study of management of the affairs of optometric practice.

"Self-instructed media" means educational material in a printed, audio, video, electronic or distance learning format.

"Topical diagnostic pharmaceutical agent," as used in A.R.S. § 32-1728, means an externally applied prescription or non-prescription substance used to examine and diagnose disease and conditions of the eye and its adnexa.

"Topical therapeutic pharmaceutical agent," as used in A.R.S. § 32-1728, means an externally applied prescription or non-prescription substance used to treat disease of the eye and its adnexa.

"Vision rehabilitation" means an individualized course of treatment and education prescribed to improve conditions of the human eye or adnexa or develop compensatory approaches. Vision rehabilitation is designed to help individuals learn, relearn, or reinforce specific vision skills, including eye movement control, focusing control, eye coordination, and the teamwork of the two eyes. Vision rehabilitation includes, but is not limited to optical, non-optical, electronic, or other assistive treatments.

Ariz. Admin. Code § R4-21-101

Former Rule Section 1. Former Section R4-21-01 repealed, new Section R4-21-101adopted effective February 7, 1986 (Supp. 86-1). Amended effective April 1, 1991 (Supp. 91-2). Amended effective November 5, 1998 (Supp. 98-4). Amended by final rulemaking at 6 A.A.R. 3812, effective September 13, 2000 (Supp. 00-3). Amended by final rulemaking at 11 A.A.R. 1864, effective May 3, 2005 (Supp. 05-2). Amended by final rulemaking at 14 A.A.R. 12, effective February 2, 2008 (Supp. 07-4). Amended by final rulemaking at 22 A.A.R. 328, effective 3/28/2016. Amended by final rulemaking at 25 A.A.R. 431, effective 4/5/2019.